Efferon Jsc
Clinical trials sponsored by Efferon Jsc, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New device aims to clean blood of burn toxins Results expected Dec 2026 (estimated)
- Blood filter may calm the deadly inflammation of cardiogenic shock Results expected Apr 2027 (estimated)
- Blood filter device aims to tame severe IBD flares Results expected Sep 2027 (estimated)
-
Filtering blood to tame Pancreatitis's cytokine storm
Disease control CompletedResearchers test a blood purification device called Efferon CT combined with high-volume hemofiltration in adults with acute pancreatitis. The goal is to see if removing inflammatory molecules from the blood reduces organ dysfunction and improves recovery. The trial enrolls 28 pa…
Sponsor: Efferon JSC • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Blood filter shows promise for severe psoriasis in early trial
Disease control CompletedThis completed pilot study tested whether filtering inflammatory molecules from the blood using a device called Efferon CT can help people with severe psoriasis. Sixty adults with moderate to severe plaque psoriasis received the treatment, which involves circulating blood through…
Sponsor: Efferon JSC • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New blood filter for sepsis: does it remove Life-Saving antibiotics?
Knowledge-focused CompletedThis study looked at whether a blood-filtering device called Efferon LPS removes antibiotics from the blood of people with sepsis. Sepsis is a severe infection that can lead to organ failure, and doctors sometimes use filters to clean the blood. The study included 30 patients and…
Sponsor: Efferon JSC • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC